Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT00820560
Eligibility Criteria:
Inclusion Criteria:
* Either non-small cell lung cancer, hormone-refractory prostate cancer, colorectal cancer, breast cancer, or squamous cell cancer of the head and neck that is refractory to standard treatment or for which no effective treatment exists. The patient must have a life expectancy of 12 weeks or longer.
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Exclusion Criteria:
* Received any anticancer medications in the 28 days prior to receiving their first dose of study medication
* Evidence of venous thrombosis by flow Doppler examination at Screening
* A history of thrombosis or a coagulation disorder
* Patients with a contraindication to use of low dose warfarin and/or aspirin.
* Any unresolved toxicity greater than grade 2 from previous anticancer therapy, except for stable chronic toxicities not expected to resolve
* Brain metastases or spinal cord compression
* Impaired renal function
* Inadequate bone marrow reserve
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00820560
Study Brief:
Protocol Section:
NCT00820560